Aspira Women's Health Inc.
NASDAQ:AWH
0.86 (USD) • At close November 5, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Aspira Women's Health Inc. |
Symbool | AWH |
Munteenheid | USD |
Prijs | 0.864 |
Beurswaarde | 13,878,345 |
Dividendpercentage | 0% |
52-weken bereik | 0.74 - 5.65 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Ms. Nicole Sandford CPA |
Website | https://aspirawh.com |
An error occurred while fetching data.
Over Aspira Women's Health Inc.
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)